DuPont and Caribou Biosciences, a developer of CRISPR-Cas technologies for genome editing, have announced a strategic alliance.
IFT Daily News
DuPont and Caribou Biosciences, a developer of CRISPR-Cas technologies for genome editing, have announced a strategic alliance.
IFT Daily News
Leave a Comment